Kynam Capital Management, LP

Holdings History for Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

Symbol: BNR on Nasdaq
Investment type: Equity / American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share
Latest Disclosed Shares Owned: 994,883 shares
Security Ownership %: 11%

Shares, Excluding Options vs Price

Value, Excluding Options

Kynam Capital Management, LP ownership in Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

14 Nov 2025 - Kynam Capital Management, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 994,883 shares of Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR). This represents 11% ownership of the company. This is the first filing by Kynam Capital Management, LP disclosing ownership of Burning Rock Biotech Ltd American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Kynam Capital Management, LP	11%			994,883				13G/A	30 Sep 2025	14 Nov 2025, 12:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.78%	$0	0	-9,640,914	-100%		Q2 2024
31 Mar 2024	0.78%	+0.08%	$7,019,549	9,640,914	+946,488	+11%	$0.73	Q1 2024
31 Dec 2023	0.92%	+0.02%	$8,085,816	8,694,426	+194,426	+2.3%	$0.93	Q4 2023
30 Sep 2023	1.4%	0%	$8,245,000	8,500,000	0		$0.97	Q3 2023
30 Jun 2023	2.8%	+0.16%	$18,309,473	8,500,000	+479,375	+6%	$2.15	Q2 2023
31 Mar 2023	2.9%	+0.23%	$22,537,956	8,020,625	+629,044	+8.5%	$2.81	Q1 2023
31 Dec 2022	2.6%	+0.24%	$16,631,057	7,391,581	+687,718	+10%	$2.25	Q4 2022
30 Sep 2022	3.5%	+1.2%	$16,022,000	6,703,863	+2,403,863	+56%	$2.39	Q3 2022
30 Jun 2022	3.2%	+2.6%	$12,513,000	4,300,000	+3,526,886	+456%	$2.91	Q2 2022
31 Mar 2022	2.3%	+1.2%	$7,182,000	773,114	+390,650	+102%	$9.29	Q1 2022
31 Dec 2021	1.9%	0%	$3,645,000	382,464	0		$9.53	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.